Capturing cancer cells with peptide bead technology

利用肽珠技术捕获癌细胞

• 批准号: 6446600
• 负责人: DERICK LAU
• 金额: $ 14.83万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-03-18 至 2004-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6446600
• 关键词: cell adhesion; cell sorting; flow cytometry; high throughput technology; human tissue; lung neoplasms; neoplasm /cancer genetics; neoplastic cell; oncogenes; peptides; pleural cavity effusion; point mutation; polymerase chain reaction; polystyrenes; single strand conformation polymorphism; technology /technique development

The purpose of this proposal is to develop a peptide-based technology to capture and expand cancer cells in body fluids, specifically pleural effusion. Pleural effusion is a common complication associated with malignancies especially lung cancer. The sensitivity is generally low in detecting cancer cells in pleural fluid by conventional cytologic methods. Detection of cancer cells in body fluids is commonly limited by the small number of malignant cells which are obscured by the presence of mesothelial cells, normal blood cells, fibroblasts, microorganisms and cellular debris. In our laboratory, we have identified peptide ligands with high affinity for malignant cells using the technology of 'one-bread one-peptide' combinatorial library invented by the co-investigator, Dr. Kit Lam. A sensitive and specific cell-growth-on-bead assay has also been developed in our laboratory for screening millions of peptide beads for specific peptide motifs to use epithelial cancer cells can attach and grow. Using this method, we have identified peptide specific motifs specific for cell- surface receptors of human malignant cell lines such as that from non- small cell lung cancers. To date, we have identified two specific hexapeptides with high affinity for lung cancer cells. Using beads conjugated with these peptides, pilot studies have demonstrated the feasibility of isolating epithelial cells from pleural fluids with proven malignant cells amid a large number of red blood cells and cell debris. We hypothesize that malignant cells from pleural fluid can be isolated, enriched and preserved by the cell-growth-on-bead assay using beads conjugated with the two specific hexapeptide ligands that we have identified to date. The specific aims of this proposal are formulated as cells: 1. To synthesize, in large scale, beads carrying one of these two specific hexapeptide motifs; 2. To optimize conditions of cell-growth- on-bead assay using these peptide beads to capture and expand epithelial cells from pleural fluid; 3. To develop methods to preserve and identify malignant cells enriched from the cell-growth-on-bead assay; 4. To develop a high-yield and high-throughput technology of magnetic peptide-beads for isolating and enriching malignant cells from pleural fluid. The development of this technology will greatly enhance our ability of diagnosing malignant pleural effusion, and it will provide a model for capturing and expanding exfoliated malignant cells in other body fluids.

该提案的目的是开发一种基于肽的技术，以捕获和扩增体液中的癌细胞，特别是胸腔积液。胸腔积液是恶性肿瘤尤其是肺癌的常见并发症。常规细胞学方法检测胸水癌细胞的敏感性一般较低。体液中癌细胞的检测通常受到少量恶性细胞的限制，这些恶性细胞被间皮细胞、正常血细胞、成纤维细胞、微生物和细胞碎片的存在所掩盖。在我们的实验室中，我们已经确定了与恶性细胞具有高亲和力的肽配体，使用由共同研究者Kit Lam博士发明的“一面包一肽”组合文库技术。我们的实验室还开发了一种灵敏和特异性的珠上细胞生长测定法，用于筛选数百万个肽珠的特定肽基序，以使用上皮癌细胞可以附着和生长。使用这种方法，我们已经鉴定了对人恶性细胞系（例如来自非小细胞肺癌的细胞系）的细胞表面受体具有特异性的肽特异性基序。到目前为止，我们已经确定了两个特定的六肽与肺癌细胞的高亲和力。使用与这些肽缀合的珠，初步研究已经证明了从胸膜液中分离上皮细胞的可行性，胸膜液中含有大量红细胞和细胞碎片中的已证实的恶性细胞。我们假设，恶性细胞从胸腔积液可以分离，富集和保存的细胞生长珠上检测使用珠共轭与两个特定的六肽配体，我们已经确定了日期。该提案的具体目标如下：1.大规模合成携带这两种特定六肽基序之一的珠粒; 2. 优化使用这些肽珠捕获和扩增来自胸水的上皮细胞的珠上细胞生长测定的条件; 3. 开发保存和鉴定从细胞生长珠测定中富集的恶性细胞的方法; 4.目的建立一种高产量、高通量的磁珠技术，用于胸水恶性肿瘤细胞的分离富集。 该技术的发展将大大提高我们诊断恶性胸腔积液的能力，并将为捕获和扩增其他体液中脱落的恶性细胞提供模型。